Login to Your Account



Better patents or cheaper drugs? India pharma caught in tough dilemma

By Carmen Ho
Staff Writer

Thursday, August 31, 2017

HONG KONG – Tensions have been building in India’s pharmaceutical sector as it tries to resolve a tricky dilemma. Stronger IP protection is needed to sustain the country’s rapid economic growth.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription